As per the analysis by Triton Market Research, Europe’s insulin patch pump market will develop at a CAGR of 10.00% during the forecasted period from 2023 to 2030. Poland, Spain, the United Kingdom, Germany, France, Italy, and Rest of Europe are scrutinized in this region’s market.
According to the World Bank’s estimates, in 2021, the diabetes prevalence in Poland was 6.8% for people in the age group of 20 to 79 years. Additionally, as per the IDF’s data, diabetes-related expenditure per person in the country was $994.3 that year.
The increasing occurrence of diabetes and the presence of supportive healthcare programs in the country are expected to drive demand for insulin patch pumps in the country. This, in turn, will foster the market’s growth over the forecast period.
The rising prevalence of diabetes and an increasing aging population are likely to drive market expansion in Italy over the forecast period. The nation has a well-developed diabetes care system, with a number of diabetic centers.
The National Diabetes Plan provides recommendations for improving the quality of diabetes care with a patient-centric approach. A rising number of government programs have increased awareness about diabetes self-management, which is expected to foster the studied market’s growth in the country over the projected period.
The countries assessed in Rest of Europe include Denmark, Belgium, Norway, and Switzerland, among others. The growing advancements in medical device technology and the rising prevalence rate of diabetes are expected to drive the studied market’s growth in the region over the coming years.
Competitive Outlook
The notable players thriving in the insulin patch pump market include Tandem Diabetes Care Inc, Terumo Corporation, Insulet Corporation, F Hoffmann La Roche AG, and Debiotech SA.
1. Europe Insulin Patch Pump Market – Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Insulin Patch Pump Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Industry Components
2.5.1. Research And Development
2.5.2. Development Of Product
2.5.3. Distribution
2.6. Regulatory Framework
2.7. Key Buying Impact Analysis
2.7.1. Price
2.7.2. Properties Of Product
2.7.3. Purpose
2.8. Key Market Strategies
2.8.1. Collaborations
2.8.2. Product Launches
2.8.3. Mergers & Acquisitions
2.9. Market Drivers
2.9.1. Growing Awareness About Insulin Patch Pumps
2.9.2. Integration Of Advanced Technologies
2.9.3. Rising Prevalence Of Diabetes Around The Globe
2.10. Market Challenges
2.10.1. Risks Related To The Use Of Insulin Pumps
2.10.2. Lack Of Knowledge Pertaining To Usage
2.10.3. Strict Regulations By Government Authorities
2.11. Market Opportunities
2.11.1. Increasing Popularity Of Glucose Monitoring Systems
2.11.2. Use Of Artificial Intelligence & Machine Learning For Manufacturing Of Insulin Pumps
2.11.3. Growing Expenditure On Diabetes Care
2.11.4. Rising Demand For Minimally Invasive Delivery Systems
2.12. Analyst Perspective
3. Europe Insulin Patch Pump Market – By Product Type
3.1. Disposable
3.2. Reusable
4. Europe Insulin Patch Pump Market – By Disease Indication
4.1. Type 1 Diabetes
4.2. Type 2 Diabetes
5. Europe Insulin Patch Pump Market – By Delivery Mode
5.1. Basal
5.2. Bolus
5.3. Basal & Bolus
6. Europe Insulin Patch Pump Market – By Distribution Channel
6.1. Online Pharmacies
6.2. Retail Pharmacies
6.3. Hospital Pharmacies
7. Europe Insulin Patch Pump Market – Country Outlook
7.1. Country Analysis
7.1.1. United Kingdom
7.1.1.1. United Kingdom Insulin Patch Pump Market Forecast & Prospects